Stay updated on Pexa-Vec and Nivolumab Combo in HCC Clinical Trial

Sign up to get notified when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The clinical trial record for NCT03071094 is now displayed, including its terminated status, study design, eligibility criteria, locations, and outcome measures.
    Difference
    47%
    Check dated 2026-11-08T04:15:07.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the study record remains inaccessible behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T01:02:56.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T01:05:36.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T00:50:40.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The 403 error page's footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T01:17:37.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Access to the study record appears blocked by a 403 Forbidden page. The page content that previously displayed the study details is not accessible due to a server/permission restriction.
    Difference
    18%
    Check dated 2026-09-20T00:22:30.000Z thumbnail image

Stay in the know with updates to Pexa-Vec and Nivolumab Combo in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.